On Monday, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic ...
Hosted on MSN12mon
Glendale country club treats pond that had 7 times the expected level of key chemicalCorrections & Clarifications: Information about the phosphorous levels expected in a man-made lake was added to this article, and the headline was updated. Executives with Arrowhead Country Club ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback